Cardlytics Inc (NASDAQ:CDLX) CEO Scott D. Grimes sold 6,000 shares of the firm’s stock in a transaction dated Thursday, August 8th. The stock was sold at an average price of $30.99, for a total value of $185,940.00. The sale was disclosed in a filing with the SEC, which is accessible through this link.
NASDAQ:CDLX opened at $32.90 on Friday. Cardlytics Inc has a fifty-two week low of $9.80 and a fifty-two week high of $34.30. The company has a debt-to-equity ratio of 0.99, a current ratio of 2.37 and a quick ratio of 2.37. The company has a market cap of $618.63 million, a PE ratio of -15.37 and a beta of 1.76. The company’s 50-day simple moving average is $27.77.
Cardlytics (NASDAQ:CDLX) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.12) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.35) by $0.23. Cardlytics had a negative return on equity of 84.02% and a negative net margin of 25.53%. The business had revenue of $48.73 million for the quarter, compared to analysts’ expectations of $43.77 million. During the same quarter in the previous year, the business posted ($0.21) EPS. Cardlytics’s revenue for the quarter was up 37.0% on a year-over-year basis. Equities analysts anticipate that Cardlytics Inc will post -1.12 earnings per share for the current year.
Large investors have recently added to or reduced their stakes in the company. Bank of Montreal Can lifted its holdings in shares of Cardlytics by 16,371.4% during the 2nd quarter. Bank of Montreal Can now owns 1,153 shares of the company’s stock valued at $30,000 after purchasing an additional 1,146 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new stake in Cardlytics in the 2nd quarter valued at approximately $60,000. Rockefeller Capital Management L.P. acquired a new stake in Cardlytics in the 2nd quarter valued at approximately $85,000. Acadian Asset Management LLC acquired a new stake in Cardlytics in the 2nd quarter valued at approximately $161,000. Finally, Gamco Investors INC. ET AL acquired a new position in shares of Cardlytics during the 1st quarter worth approximately $256,000. Institutional investors and hedge funds own 71.09% of the company’s stock.
Cardlytics Company Profile
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
Read More: How to Trade Using Analysts Ratings
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.